The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
one of the areas where maps could use support as I understand it is in taking their approach to legitimizing MDMA use therapeutically in the US to Europe so there will be steps they'll take with the EMA I think it is which is the FDA equivalent in the EU for hopefully facilitating MDMA use in Europe
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.